Abstract
Purpose
Schizophrenia is associated with increased premature mortality and physical morbidity. This study aimed to examine prevalence of pre-existing chronic physical diseases, and association between physical multimorbidity burden and mortality rates among patients with newly diagnosed schizophrenia.
Methods
This population-based cohort study investigated patients with first-recorded diagnosis of schizophrenia between January 2006 and December 2016, using territory-wide medical-record database of public healthcare service in Hong Kong. Physical morbidities were measured by Charlson Comorbidity Index (CCI), taking into consideration both number and severity of physical diseases, and were grouped into nine broad disease categories for analyses. Physical multimorbidity burden was stratified into three levels according to CCI of 0, 1 or ≥ 2. Cox proportional hazards regression models were used to examine associations of physical multimorbidity with mortality rates.
Results
Of the 13,945 patients, 8.6% (n = 1207) had pre-existing physical morbidity. Patients with physical morbidity exhibited elevated all-cause mortality rate relative to those without physical morbidity [adjusted HR 2.38 (95% CI 2.04–2.77)]. Gastrointestinal/liver diseases, diabetes and cardiovascular diseases constituted the three most frequently diagnosed physical morbidities, whereas cancers displayed the highest all-cause mortality rate. An increase in physical multimorbidity burden was associated with increased all-cause mortality rate [CCI = 1: 1.98 (1.64–2.40); CCI ≥ 2: 3.08 (2.51–3.77), CCI = 0 as reference].
Conclusion
Schizophrenia patients with pre-existing physical morbidity had two-fold increased risk of premature mortality compared to those without physical morbidity. Physical multimorbidity confers incremental impact on excess mortality. Early detection and intervention of physical morbidity in the initial phase of schizophrenia is necessary to reduce avoidable mortality.
Similar content being viewed by others
References
Chang WC, Wong CSM, Chen EYH et al (2017) Lifetime prevalence and correlates of schizophrenia-spectrum, affective, and other non-affective psychotic disorders in the Chinese adult population. Schizophr Bull 43:1280–1290
Simeone JC, Ward AJ, Rotella P, Collins J, WIndisch R, (2015) An evaluation of variation in published estimates of schizophrenia prevalence from 1990–2013: a systematic literature review. BMC Psychiatry 15:193
Global Burden of Disease Study (2013) Collaborators (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386:743–800
Hjorthøj C, Stürup AE, McGrath JJ et al (2017) Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry 4:295–301
Oakley P, Kisely S, Baxter A et al (2018) Increased mortality among people with schizophrenia and other non-affective psychotic disorders in the community: a systematic review and meta-analysis. J Psychiatr Res 102:245–253
Plana-Ripoll O, Pedersen CB, Agerbo E et al (2019) A comprehensive analysis of mortality-related health metrics associated with mental disorders: a nationwide, register-based cohort study. Lancet 394:1827–1835
Yung CL, Wong SM, Chan KN, Chen EYH, Chang WC (2021) Excess mortality and life-years lost in people with schizophrenia and other non-affective psychoses in Hong Kong: a 11-year population-based cohort study. Schizophr Bull 47:474–484
Laursen TM, Nordentoft M, Mortensen PB (2014) Excess early mortality in schizophrenia. Annu Rev Clin Psychol 10:425–448
Laursen TM, Plana-Ripoll O, Andersen PK et al (2019) Cause-specific life years lost among persons diagnosed with schizophrenia: is it getting better or worse? Schizophr Res 206:284–290
Crump C, Winkleby MA, Sundquist K et al (2013) Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry 170:324–333
Kugathasan P, Stubbs B, Aagaard J et al (2019) Increased mortality from somatic multimorbidity in patients with schizophrenia: a Danish nationwide cohort study. Acta Psychiatr Scand 140:340–348
Correll CU, Ng-Mak DS, Stafkey-Mailey D, Farrelly E, Rajagopalan K, Loebel A (2017) Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis. Ann Gen Psychiatry 16:9
Gabilondo A, Alonso-Moran E, Nuño-Solinis R, Orueta JF, Iruin A (2017) Comorbidities with chronic physical conditions and gender profiles of illness in schizophrenia: results from PREST, a new health dataset. J Psychosom Res 93:102–109
Laursen TM, Munk-Olsen T, Gasse C (2011) Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PloS One 6(9):e24597.
Nguyen TT, Eyler LT, Jeste DV (2018) Systematic biomarkers of accelerated aging in schizophrenia: a critical review and future directions. Schizophr Bull 44:398–408
Filipčić IŠ, Bajić Ž, Filipčić I (2020) The onset and accumulation of physical multimorbidity in severe and common mental disorders. Curr Opin Psychiatry 33(5):484–490
Smith DJ, Langan J, McLean G, et al (2013) Schizophrenia is associated with excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in primary care: Cross-sectional study. BMJ Open 3(4):e002808.
Stubbs B, Koyanagi A, Veronese N et al (2016) Physical multimorbidity and psychosis: Comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countries. BMC Med 14:189
Bitter I, Czobor P, Borsi A et al (2017) Mortality and the relationship of somatic comorbidities to mortality in schizophrenia. A nationwide matched-cohort study. Eur Psychiatry 45:97–103
Kugathasan P, Wu H, Gaughran F et al (2020) Association of physical health multimorbidity with mortality in people with schizophrenia spectrum disorders: using a novel semantic search system that captures physical diseases in electronic patient records. Schizophr Res 216:408–415
Chen YL, Pan CH, Chang CK et al (2020) Physical illnesses before diagnosed as schizophrenia: a nationwide case-control study. Schizophr Bull 46(4):785–794
Sørensen HJ, Nielsen PR, Benros ME, Pedersen CB, Mortensen PB (2015) Somatic diseases and conditions before the first diagnosis of schizophrenia: a nationwide population-based cohort study in more than 900 000 individuals. Schizophr Bull 41:513–521
Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613–619
Hospital Authority Head Office IT Department (2003) Clinical Data Analysis & Reporting System (CDARS) User’s Manual: 2.0 ed. Hong Kong: Hong Kong Hospital Authority; 3.
Cheung NT, Fung V, Wong WN et al (2007) Principles-based medical informatics for success—How Hong Kong built one of the world’s largest integrated longitudinal electronic patients records. Stud Health Technol Inform 129(Pt 1):307–310
Chan JKN, Wong CSM, Or PCF, Chen EYH, Chang WC (2021) Risk of mortality and complications in patients with schizophrenia and diabetes mellitus: a population-based cohort study. Br J Psychiatry doi:https://doi.org/10.1192/bjp.2020.248. [Online ahead of print].
Chang WC, Chan JKN, Wong CSM, Hai SH, Or PCF, Chen EYH (2020) Mortality, revascularization, and cardioprotective pharmacotherapy after acute coronary syndrome in patients with psychotic disorders: a population-based cohort study. Schizophr Bull 46:774–784
Yung CL, Wong SM, Chan KN et al (2019) Mortality in patients with schizophrenia admitted for incident ischemic stroke: a population-based cohort study. Eur Neuropsychopharmacol 31:152–157
Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
Pillinger T, Beck K, Gobjila C, Donocik JG, Jauhar S, Howes OD (2017) Impaired glucose homeostasis in first-episode schizophrenia: a systematic review and meta-analysis. JAMA Psychiat 74:261–269
Rajkumar AP, Horsdal HT, Wimberley T et al (2017) Endogenous and antipsychotic-related risks for diabetes mellitus in young people with schizophrenia: a Danish population-based cohort study. Am J Psychiatry 174:686–694
Henderson DC, Vincenzi B, Andrea NV, Ulloa M, Copeland PM (2015) Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. Lancet Psychiatry 2:452–264
Ferrer A, Formiga F, Sanz H, Almeda J, Padros G (2017) Multimorbidity as specific disease combinations, an important predictor factor for mortality in octogenarians: the Octabaix study. Clin Interv Aging 12:223–231
Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS (2015) Premature mortality among adults with schizophrenia in the United States. JAMA Psychiat 72:1172–1181
Brown DW, Anda RF, Tiemeier H et al (2009) Adverse childhood experiences and risk of premature mortality. Am J Prev Med 11:389–396
Tsai KY, Chung TC, Lee CC et al (2014) Is low individual socioeconomic status (SES) in high-SES areas the same as low individual SES in low-SES areas: a 10-year follow-up schizophrenia study. Soc Psychiatry Psychiatr Epidemiol 49:89–96
Moreno-Küstner B, Guzman-Parra J, Pardo Y, Sanchidrián Y, Díaz-Ruiz S, Mayoral-Cleries F (2021) Excess mortality in patients with schizophrenia spectrum disorders in Malaga (Spain): a cohort study. Epidemiol Psychiatr Sci 30:e11.
Davis KA, Sudlow CL, Hotopf M (2016) Can mental health diagnoses in administrative data be used for research? A systematic review of the accuracy of routinely collected diagnoses. BMC Psychiatry 16:263
Acknowledgements
The authors would like to thank the colleagues in Hospital Authority for their kind assistance in data retrieval for the current investigation.
Funding
The study was supported by the Hong Kong Research Grants Council (17124715). Additional financial support to undertake this research was provided by the State Key Laboratory of Brain & Cognitive Sciences, the University of Hong Kong.
Author information
Authors and Affiliations
Contributions
Authors WCC, CSMW and JKNC designed and conceptualized the study. Author JKNC conducted statistical analysis and wrote the first draft of the manuscript. Authors WCC, JKNC and CSMW interpreted the study data. Author WCC revised and finalized the manuscript. All authors provided critical feedback to the manuscript and have approved the final manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chan, J.K.N., Wong, C.S.M., Yung, N.C.L. et al. Pre-existing chronic physical morbidity and excess mortality in people with schizophrenia: a population-based cohort study. Soc Psychiatry Psychiatr Epidemiol 57, 485–493 (2022). https://doi.org/10.1007/s00127-021-02130-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00127-021-02130-9